Tommaso Mari
Bayer (United States)(US)Bayer (Germany)(DE)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, Microtubule and mitosis dynamics, Advanced Proteomics Techniques and Applications, Cancer, Hypoxia, and Metabolism, Bioinformatics and Genomic Networks
Most-Cited Works
- → SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis(2021)531 cited
- → Transcriptomic profiling of SARS-CoV-2 infected human cell lines identifies HSP90 as target for COVID-19 therapy(2021)290 cited
- → Bulk and single-cell gene expression profiling of SARS-CoV-2 infected human cell lines identifies molecular targets for therapeutic intervention(2020)85 cited
- → In Vitro Kinase-to-Phosphosite Database (iKiP-DB) Predicts Kinase Activity in Phosphoproteomic Datasets(2022)44 cited
- → Chromatin proteomics reveals novel combinatorial histone modification signatures that mark distinct subpopulations of macrophage enhancers(2017)34 cited
- → MACC1 regulates clathrin-mediated endocytosis and receptor recycling of transferrin receptor and EGFR in colorectal cancer(2021)21 cited
- → Neuroblastoma signalling models unveil combination therapies targeting feedback-mediated resistance(2021)11 cited
- → Streamlining cellular thermal shift assay for ultra-high throughput screening(2025)